Skip to content

Radiographic Findings and Clinical Outcomes After Bone Grafting Patellar Defect in ACL Reconstruction

Radiographic Findings and Clinical Outcomes After Bone Grafting Patellar Defect in ACL Reconstruction

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06975306
Acronym
BTB BackFill
Enrollment
75
Registered
2025-05-16
Start date
2025-02-11
Completion date
2027-04-30
Last updated
2026-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ACL Injuries, Bone Graft; Complications

Brief summary

All patients will be randomly assigned using a computer randomization algorithm to one of two matched cohort groups. Patients will not be advised which group they belong to until after the completion of the study. One group will be treated with autologous bone graft for bone patellar-tendon bone (BTB) Anterior Cruciate Ligament Reconstruction (ACLR), and the other group will be treated with commercially available DBM (Demineralized bone matrix) putty. Patients will be enrolled from Banner University. Before and after surgery, patient reported outcomes including visual analog pain scale (VAS), Tegner-Lysholm and Cincinnati ACL Test. The principal investigator will evaluate the patients on subjective criteria such as pain and objective criteria including range of motion, arthritic changes seen on radiographs, infection, and ability to kneel.

Interventions

PROCEDUREautologous bone grafts

group will be treated with autologous bone graft for BTB ACLR

OTHERDemineralized bone matrix (DBM)

Demineralized bone matrix (DBM) is a biologic allograft product derived from bone tissue that has undergone a process of demineralization to remove inorganic mineral components while retaining the organic matrix, including proteins and growth factors.

Sponsors

University of Arizona
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* 18-40 years old, * male/female/gender neutral, * all races not including vulnerable/special consideration populations, * candidate for anterior cruciate ligament reconstruction with bone patellar bone autograft, * compliant post operative course.

Exclusion criteria

* \< 18, \>41 years of age, * prior bone patellar bone anterior cruciate ligament reconstruction, * non-compliance post-operatively, * nicotine dependence.

Design outcomes

Primary

MeasureTime frameDescription
change in surgical timeDuration of Procedure
Change in number of complications from the coring reamer intra-operativelyDuration of Procedure
Change in number of complications associated with displacement of the bone graft1 year post procedure
Change in outcomes by immediately filling the patellar void following BTB graft harvest1 year post procedureChange in outcomes by immediately filling the patellar void following BTB graft harvest, as assessed by the Tegner-Lysholm Knee Scoring Scale

Countries

United States

Contacts

CONTACTMarleny Munoz
marlenymunoz@arizona.edu602-793-9582
CONTACTPhoenix Biomedical Campus Regulatory Team
mlburchfi@arizona.edu
PRINCIPAL_INVESTIGATORAnup Shah, MD

College of Medicine - Phoenix

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 15, 2026